Ambulatory Care Pharmacy Specialty Review Course, Workbook Chapters, and Practice Exam (No Recert Credit) (L259040)
ACPE Numbers: Various – see listing below
Content Release Date: April 30, 2025
Expiration Date: April 28, 2026
Activity Type: Application-based
CE Credits: 24.5 contact hours (ACPE only)
Activity Fee: $445 (ASHP member); $665 (non-member)
Activity Overview
This online course provides a robust preparatory curriculum for the pharmacy professional preparing for the Board of Pharmacy Specialties (BPS) Ambulatory Care Specialty Certification Examination. Designed based on the domains, tasks, and knowledge statements developed by the BPS for the certification examination, this course will help you prepare for the exam by identifying areas needed for in‐depth review of ambulatory care issues by:
- Reviewing pertinent clinical topics and practice skills
- Listing valuable references for further study
This course is NOT intended for those obtaining recertification credit. To earn recertification credit, please see courses here: http://elearning.ashp.org/catalog/amb-care-recert
These activities are part of the ACCP and ASHP professional development program.
Accreditation
![]() |
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation. |
![]() |
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education. |
Target Audience
These activities are intended for pharmacists who are seeking to update their knowledge and skills commensurate with a board certification examination in the areas listed below.
Review Course
This course consists of 19 activities (see table below) and provides up to 24.5 contact hours of continuing pharmacy education credit. The Review Course includes case-based presentations for application to real-life scenarios, links to the reference sources, and domains, tasks, and knowledge statements.
Learning Activity |
ACPE Number |
Contact Hours |
Date |
|
Developing and Managing a Clinical Practice |
|
|
|
|
Communication Strategies in Pharmacy |
||||
Dermatologic and Eyes, Ears, Nose and Throat, and Immunological Disorders |
||||
Psychiatric Disorders |
0217-9999-25-055-H01-P |
3.5 ACPE |
04/30/2028 | |
Neurology |
||||
Bone/Joint and Rheumatology |
||||
Cardiology I |
0217-9999-25-056-H01-P | 4.5 ACPE | 04/30/2028 | |
Cardiology II |
||||
Pulmonary Disorders |
||||
Diabetes |
0217-9999-25-057-H01-P | 4.0 ACPE | 04/30/2028 | |
Endocrine Disorders |
||||
Nephrology |
||||
Infectious Diseases I |
0217-9999-25-058-H01-P | 3.25 ACPE | 04/30/2028 | |
Infectious Diseases II |
||||
Gastrointestinal Disorders |
||||
Genitourinary, Electrolytes, and Nutritional Deficiencies/Supplementation in Older Adults |
0217-9999-25-059-H01-P |
3.25 ACPE |
04/30/2028 |
|
Obstetrics and Gynecology |
||||
Practices and Processes of Care |
||||
Trial Design and Biostatistics |
0217-9999-25-060-H01-P |
2.5 ACPE |
04/30/2028 |
Learning Objectives
After participating in this CPE activity, learners should be able to:
ACPE Number: 0217-9999-25-054-H01-P
Developing and Managing a Clinical Practice
- Demonstrate the steps to identify the need for and implement pharmacist-provided patient care services in the ambulatory care setting.
- Design a robust and sustainable quality assessment program for pharmacist-provided patient care services in the ambulatory care setting.
- Summarize considerations for ongoing management of an ambulatory care service.
- Examine revenue-generating opportunities for pharmacist-provided patient care services in different ambulatory care settings.
Communication Strategies in Pharmacy
- Use strategies that develop patient rapport, foster trust, and effectively and efficiently obtain accurate, comprehensive histories, despite potential barriers in communication.
- Use assessments of patients’ knowledge, health literacy, self-management skills, health beliefs, and attitudes toward medications to tailor educational interventions that will improve medication therapy adherence and self-efficacy.
- Communicate medication-related information and pharmacist-directed patient care interventions effectively to other health care professionals both verbally and in writing through the medical record.
- Discuss factors and methods used to assess and select age- and grade-level appropriate written educational materials intended for a variety of patient types.
Dermatologic and Eyes, Ears, Nose, and Throat, and Immunologic Disorders
- Formulate an ophthalmologic drug therapy regimen for a patient presenting with macular degeneration, dry eye syndrome, or glaucoma.
- Construct an individualized pharmacy care plan for a patient with allergic rhinitis.
- Initiate, change, and modify topical and oral therapeutic regimens for acne using a treatment algorithm.
- Recommend topical and systemic agents for treating plaque psoriasis given a patient’s disease presentation, severity, and prior therapies.
- Effectively educate a patient presenting with a skin infestation or minor burn on the purpose, proper use, and potential adverse reactions of treatment.
ACPE Number: 0217-9999-25-055-H01-P
Psychiatric Disorders
- Analyze the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR) criteria and disease course for anxiety disorders, sleep disorders, major depression, bipolar disorder, attention-deficit/hyperactivity disorder, schizophrenia, and substance use disorders.
- Apply a working knowledge of common drug and nondrug therapies for psychiatric disorders, including drug, dose, frequency, adverse effects, drug interactions, and monitoring values.
- Recommend appropriate treatments, including both lifestyle modification and specific drug therapy (medication dose, schedule, and delivery system), on the basis of relevant patient factors (pharmacodynamic, physiologic, pharmacokinetic, and socioeconomic parameters).
- Develop a patient-specific monitoring plan including medication effectiveness, adverse drug reactions, and drug and disease state interactions.
Neurology
- Given a patient case, select an appropriate antiseizure medication (ASM) regimen for a patient with epilepsy on the basis of seizure type and ASM mechanism of action, common adverse effects, and drug interactions.
- Provide a recommendation for an appropriate pharmacologic therapy for a patient with episodic or chronic migraine headache.
- Select and manage appropriate disease-modifying therapy for a patient with multiple sclerosis (MS) on the basis of MS subtype and other patient-specific factors.
- Recommend an appropriate pharmacologic therapy for a patient with Parkinson disease, neuropathic pain, or Alzheimer disease.
Bone/Joint and Rheumatology
- Identify patients at risk of/presenting with osteoporosis (OA) for further screening and recommend an appropriate therapy plan to prevent future fractures.
- Recommend therapy for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and systemic lupus erythematosus (SLE) on the basis of clinical practice guidelines and patient-specific factors.
- Recommend screenings, laboratory tests, or immunizations at appropriate intervals for patients with RA, PsA, or SLE treated with disease-modifying antirheumatic drug (DMARD) or biologic DMARD therapies.
- Choose appropriate drug therapy for OA or fibromyalgia on the basis of drug efficacy and a patient’s comorbid conditions.
- Formulate a care plan to help patients decrease their uric acid concentrations, gout symptoms, and gouty attacks using nonpharmacologic and pharmacologic interventions.
ACPE Number: 0217-9999-25-056-H01-P
Cardiology I
- Evaluate the appropriate use of aspirin for primary prevention of cardiovascular events according to practice guidelines and clinical trial evidence.
- Design an evidence-based treatment and monitoring strategy for patients with hypertension that considers goals of therapy, comorbid conditions, and compelling indications.
- Create an evidence-based treatment and monitoring plan for patients receiving lipid-lowering therapies for primary and secondary prevention of atherosclerotic cardiovascular disease and hypertriglyceridemia.
- Devise an evidence-based treatment plan for secondary prevention of acute coronary syndrome, chronic coronary disease, stroke and transient ischemic attack, and peripheral arterial disease.
Cardiology II
- Formulate appropriate oral anticoagulant treatment strategies for patients who develop venous thromboembolism (deep venous thrombosis or pulmonary embolism), nonvalvular atrial fibrillation, or who have mechanical heart valves consistent with available consensus panel guidelines, recent U.S. Food and Drug Administration approvals, and randomized clinical trials.
- Describe key differences in onset of action, dosing, administration, absorption, effects on common coagulation tests, and drug interactions between dabigatran, rivaroxaban, apixaban, edoxaban, and warfarin.
- Develop patient-specific, guideline-driven treatment, monitoring, and follow-up plans for patients with heart failure, atrial fibrillation, or ventricular tachycardia.
- Identify treatment goals, common adverse effects, clinically important drug interactions, monitoring, and risk evaluation and mitigation strategies requirements for oral pharmacotherapy of pulmonary arterial hypertension.
Pulmonary Disorders
- Compare and contrast common features of patients with asthma, chronic obstructive pulmonary disease (COPD), or both.
- Select appropriate evidence-based treatment for patients with asthma, COPD, and/or nicotine dependence based on specific patient factors and comorbidities.
- Develop a comprehensive education plan with monitoring parameters for patients on therapy for asthma, COPD, and/or smoking cessation.
- Compare and contrast the different respiratory inhaler devices and holding chambers.
- Integrate smoking cessation and behavioral counseling as a best practice when assisting a patient who is trying to quit smoking.
ACPE Number: 0217-9999-25-057-H01-P
Diabetes
- Identify differences between prediabetes, type 1 diabetes (T1D), type 2 diabetes (T2D), and gestational diabetes (GD), including differences in diagnostic criteria and clinical presentation.
- Compare agents used in the treatment of diabetes, including their mechanisms of action, adverse effects, contraindications, advantages, and disadvantages.
- Select appropriate insulin regimens for patients on the basis of desired onset, peak, and duration of insulin effects.
- Individualize a comprehensive glycemic treatment and monitoring plan for a patient with prediabetes, T1D, T2D, and GD.
- Develop a treatment plan to address cardiorenal risk in a person with T2D.
- Design a treatment plan to address the acute and chronic complications related to diabetes.
Endocrine Disorders
- Design appropriate thyroid hormone replacement therapy dosing strategies for patients with hypothyroidism and hyperthyroidism.
- Develop appropriate patient-specific pharmacotherapy for the treatment of polycystic ovary syndrome.
- Medically manage a patient with hyperprolactinemia, acromegaly, and growth hormone deficiency.
- Differentiate between available weight-loss medications and design a patient-specific treatment plan.
- Design a patient-specific treatment plan, for a patient with adrenal gland disorders and Cushing disease.
- Formulate a patient specific treatment plan with appropriate monitoring guidelines for hypogonadism.
Nephrology
- Formulate an appropriate care plan to mitigate risk and slow progression in a patient at risk of developing, or presenting with, acute kidney injury, drug-induced kidney disease, or chronic kidney disease (CKD).
- Using appropriate data, assess kidney function, dialysis regimen information, and pharmacokinetic/pharmacodynamic drug properties in a patient to inform clinical decision-making.
- Construct an evidence-based treatment plan for managing the most common medical problems in patients with CKD, including anemia, CKD-related mineral and bone disorder, and hyperkalemia.
- Interpret Medicare Part B and D policies related to end-stage renal disease (ESRD) and dialysis care (i.e., ESRD Prospective Payment System, Quality Incentive Program, Conditions for Coverage, Centers for Medicare & Medicaid Services Comprehensive ESRD Care Model) and their respective effects on medication use.
ACPE Number: 0217-9999-25-058-H01-P
Infectious Diseases I
- Identify the clinical presentations of sexually transmitted infections, and design appropriate treatment regimens.
- Describe the mechanisms of action, adverse effects, and major drug interactions associated with antiretroviral agents.
- Formulate treatment strategies for the management of HIV and commonly encountered opportunistic infections.
- Design appropriate strategies for treatment and prevention of influenza and other viral infections.
- Explain the risk factors for superficial and endemic fungal infections, and design corresponding treatment regimens.
Infectious Diseases II
- Use appropriate pharmacologic and nonpharmacologic treatment regimens for patients with urinary tract infections, prostatitis, community-acquired pneumonia, sinusitis, pharyngitis, acute otitis media, skin and soft tissue infections, latent tuberculosis infection, conjunctivitis, Lyme disease, antibiotic prophylaxis, infectious diarrhea, and Clostridioides difficile infections.
- Interpret risk factors and clinical circumstances for the development of antimicrobial resistance.
- Use an antimicrobial therapeutic regimen to treat resistant infections and prevent their future development.
- Use evidence-based medicine and patient-specific factors to design antimicrobial regimens that are appropriate and cost-effective.
Gastrointestinal Disorders
- Apply national guideline–based treatment strategies for gastrointestinal (GI) disorders.
- Assess the benefit-risk of drug therapy for patients with GI disorders.
- Prepare appropriate nonpharmacologic and pharmacologic interventions for managing GI disorders.
- Develop and implement a patient-specific comprehensive therapeutic plan for managing GI disorders.
- Employ drug-related patient education and counseling for pharmacologic therapies used in managing GI disorders.
ACPE Number: 0217-9999-25-059-H01-P
Genitourinary, Electrolytes, and Nutritional Deficiencies/Supplementation in Older Adults
- Assess common genitourinary diseases, electrolyte abnormalities, and nutritional deficiencies in ambulatory older adults.
- Evaluate and manage drug-induced causes of benign prostatic hyperplasia (BPH), urinary incontinence, erectile dysfunction (ED), electrolyte abnormalities, and nutritional deficiencies in ambulatory older adults.
- Compare and contrast pharmacologic interventions for BPH, urinary incontinence, ED, electrolyte abnormalities, and nutritional deficiencies.
- Formulate treatment strategies for BPH, urinary incontinence, ED, electrolyte abnormalities, and nutritional deficiencies using patient-specific information.
Obstetrics and Gynecology
- Recommend therapy for contraception, infertility, menstrual disorders, and endometriosis on the basis of patient-specific information.
- Recommend appropriate treatment for common acute and chronic conditions in pregnancy and lactation.
- Recommend therapy for menopausal symptoms on the basis of patient-specific information.
- Develop provider and patient education regarding medication use during pregnancy and lactation, contraception, infertility, menstrual disorders, endometriosis, and postmenopausal therapy.
Practices and Processes of Care
- Illustrate a pharmacist’s role and resources regarding quality management, medication safety, and process improvement.
- Assess the different types of patient care services within ambulatory care pharmacy practice, including any applicable scope or limitations of practice.
- Use formulary management activities and other resources to improve the prescribing of and access to safe, effective, and affordable treatments.
ACPE Number: 0217-9999-25-060-H01-P
Trial Design and Biostatistics
- Describe hypothesis testing and state the meaning of and distinguish between P values, CIs, and measures of central tendency and data spread.
- Define, compare, and contrast the concepts of internal and external validity, causation, association, bias, confounding, subgroup analysis, surrogate end points, and composite end points in trial design.
- Compare and contrast the advantages and disadvantages of various study designs (e.g., prospective, retrospective, case-control, cohort, cross-sectional, randomized controlled clinical trials, systematic review, and meta-analysis).
- Determine why a statistical test is appropriate or not appropriate, given the sample distribution, data type, and study design.
- Interpret statistical and clinical significance for results from commonly used biostatistical estimation strategies (i.e., CIs) and statistical tests (i.e., P values).
- Define and evaluate odds ratio, risk/incidence rate, relative risk, number needed to treat, number needed to harm, and other risk estimates.
Faculty
Shubha Bhat, PharmD, MS, FCCP, BCACP
Clinical Pharmacist - Gastroenterology
Cleveland Clinic
Cleveland, Ohio
Brandi L. Bowers, PharmD, BCACP
Clinical Associate Professor
University of Missouri-Kansas City
Springfield, Missouri
David K. Choi, PharmD, BCACP
Associate Director
Clinical Pharmacy Specialist
University of Chicago Medicine Inflammatory Bowel Disease Center
Chicago, Illinois
Erica F. Crannage, PharmD, FCCP, BCPS, BCACP
Associate Professor, Pharmacy Practice
St. Louis College of Pharmacy at The University of Health Science & Pharmacy
Clinical Pharmacist
Mercy Clinic – Family Medicine
St. Louis, Missouri
Elizabeth Van Dril, PharmD, BCPS, BCACP
Clinical Assistant Professor
University of Illinois at Chicago
Retzky College of Pharmacy
Chicago, Illinois
Spencer H. Durham, PharmD, FCCP, BCPS, BCIDP
Assistant Clinical Professor
Department of Pharmacy Practice
Auburn University Harrison College of Pharmacy
Auburn, Alabama
Alicia B. Forinash, PharmD, FCCP, BCPS, BCACP
Professor of Pharmacy Practice
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy
St. Louis, Missouri
Nicole M. Hahn, PharmD, BCACP*
Clinical Pharmacy Specialist - Neurology
Kaiser Permanente
Denver, Colorado
Diana Isaacs, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM
Endocrine Clinical Pharmacy Specialist
Co-Director - Endocrine Disorders in Pregnancy
CGM Program Coordinator
Cleveland Clinic Endocrinology & Metabolism Institute
Cleveland, Ohio
Adam B. Jackson, PharmD, BCACP*
Clinical Pharmacy Specialist, Infectious Diseases
Kaiser Permanente Colorado
Denver, Colorado
Zachary Klick, PharmD, BCACP, BCCP, BCPS, CPP
Cardiology Pharmacist
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina
Hanlin Li, PharmD, MBA, BCACP
Lead Clinical Pharmacy Manager
NewYork-Presbyterian
New York, New York
Melissa Lipari, PharmD, BCACP
Associate Professor (Clinical)
Wayne State University
Ambulatory Care Pharmacy Specialist
Ascension St. John Hospital
Detroit, Michigan
Jamie L. McConaha, PharmD, BCACP*
Associate Professor of Pharmacy Practice
Duquesne University
Pittsburgh, Pennsylvania
Emily K. McCoy, PharmD, FCCP, BCACP
Associate Clinical Professor
Auburn University Harrison College of Pharmacy
Mobile, Alabama
Molly G. Minze, PharmD, FCCP, BCACP
Associate Professor of Pharmacy Practice
Associate Dean for Student Affairs and Admissions Abilene Campus
Jerry H. Hodge School of Pharmacy
Texas Tech University Health Sciences Center
Abilene, Texas
Melissa C. Palmer, PharmD, BCPS, BCPP
Clinical Pharmacy Practitioner – Mental Health
Alaska VA Healthcare System
Anchorage, Alaska
Jessica Tilton, PharmD, BCACP
Clinical Assistant Professor
Clinical Pharmacist
Medication Therapy Management Clinic
Clinical Coordinator
University of Illinois at Chicago
Chicago, Illinois
Emily Walsh, PharmD, BCACP
Clinical Pharmacy Specialist
University of Iowa Health Care
Adjunct Assistant Professor
University of Iowa College of Pharmacy
Iowa City, Iowa
*Content Matter Experts
Reviewers
Teresa Bailey, PharmD, FCCP, BCPS, BCACP
Professor
Ferris State University College of Pharmacy
Clinical Pharmacist
WMed Health Clinics
Kalamazoo, Michigan
Julie Bartell, PharmD, FPSW, BCACP
Pharmacotherapy Supervisor
SSM Health Monroe Clinic Medical Group
Monroe, Wisconsin
Laura Challen, PharmD, MBA, BCPS, BCACP
Associate Professor of Pharmacy Practice
University of Health Sciences and Pharmacy in St. Louis
Ambulatory Care Clinical Pharmacist
Mercy Hospital, JFK Clinic
St. Louis, Missouri
Megan Chynoweth, PharmD, BCACP, CDCES, APh
Ambulatory Care Pharmacist
Kaiser Permanente
Downey, California
Melanie K. Claborn, PharmD, BCACP
Associate Professor of Pharmacy Practice
Southwestern Oklahoma State University
Clinical Pharmacy Specialist
Oklahoma City Indian Clinic
Oklahoma City, Oklahoma
Kristen Cook, PharmD, BCACP
Clinical Associate Professor
University of Nebraska Medical Center College of Pharmacy
Clinical Pharmacist
Nebraska Medicine Patient Centered Medical Home
Omaha, Nebraska
Jennifer S. Dizney, PharmD, BCACP, BCGP, BCPP, CDCES
Clinical Pharmacist
Hartford Hospital Department of Pharmacy
Hartford, Connecticut
Ariel D. Ferdock, PharmD, BCPS, BCACP, CDCES
Clinical Pharmacist
Mayo Clinic Health Systems
La Crosse, Wisconsin
Rhianna M. Fink, PharmD, BCACP, BC-ADM
Associate Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado
Benjamin Neil Gross, PharmD, MBA, FCCP, BCPS, BCACP
Chair and Associate Professor
Lipscomb University College of Pharmacy
Nashville, Tennessee
Jason L. Isch, PharmD, BCACP
Associate Professor of Pharmacy Practice
Manchester University, College of Pharmacy
Clinical Pharmacist – Ambulatory Care
Saint Joseph Health System
South Bend, Indiana
Alana Juodvalkis, PharmD, BCACP
Ambulatory Care Clinical Pharmacist
VillageMD
Phoenix, Arizona
Karen Kier, PhD, FCCP, BCPS, BCACP
Professor of Pharmacy Practice
Director of Drug and Health Information
Raabe College of Pharmacy; Ohio Northern University
Ambulatory Care Pharmacist
Ohio Northern University HealthWise
Ada, Ohio
Chelsey Llayton, PharmD, BCACP
Assistant Professor of Pharmacy Practice
University of Charleston School of Pharmacy
Charleston, West Virginia
Kayla Marvin, PharmD, BCACP, CDCES, CPP
Ambulatory Care Clinical Pharmacist Practitioner
Atrium Health
Concord, North Carolina
Ana Muscarella, PharmD, BCACP
Clinical Pharmacy Specialist
Vanderbilt University Medical Center
Clinical Team Lead
Vanderbilt Specialty Pharmacy
Nashville, Tennessee
Assistant Professor of Pharmacy Practice
William Carey University School of Pharmacy
Clinical Pharmacist
Forrest General Hospital Family Medicine Residency Clinic
Hattiesburg, Mississippi
Casey Owen, PharmD, BCACP, CACP
Clinical Pharmacist Practitioner
VA Tennessee Valley Healthcare System
Nashville, Tennessee
Rakeshkumar Patel, PharmD, BCACP
Pharmacist
Johns Hopkins
Baltimore, Maryland
Ann M. Philbrick, PharmD, FCCP, BCACP
Associate Professor
University of Minnesota College of Pharmacy
Minneapolis, Minnesota
Lalita Prasad-Reddy, PharmD, MS, FCCP, BCACP, BCPS, CDCES
Assistant Dean for Preclerkship Education, Vice-Chair of Foundational Sciences & Humanities
Associate Professor of Clinical & Molecular of Pharmacology
Chicago Medical School, Rosalind Franklin University of Medicine & Science
Chicago, Illinois
Melanie Keaton Proffitt, PharmD, MHA, BCACP, BCMTMS
Director of Outpatient Pharmacy Operations
Methodist Dallas Medical Center
Dallas, Texas
Kristi Quairoli, PharmD, BCACP, CDCES
Clinical Pharmacist Specialist, Ambulatory Care
Director, PGY-2 Ambulatory Care Pharmacy Residency Program
Department of Pharmacy and Drug Information
Grady Health System
Atlanta, Georgia
Lavinia Salama, PharmD, BCACP, BC-ADM, CDCES
Clinical Assistant Professor
University of Wyoming—School of Pharmacy and University of Wyoming Family Medicine Residency at Cheyenne
Cheyenne, Wyoming
Rafael Sánchez, PharmD, BCACP, CDCES, AAHIVP
Clinical Assistant Professor
University of Texas at El Paso School of Pharmacy
Ambulatory Care Clinical Pharmacist
Centro de Salud Familiar – La Fe
El Paso, Texas
Joseph Saseen, PharmD, BCPS, BCACP
Professor and Associate Dean for Clinical Affairs
University of Colorado
Aurora, Colorado
Kyle V. Sheffer, PharmD, BCACP
Pharmacy Informaticist
Lawton Indian Hospital, Indian Health Service
Lawton, Oklahoma
Eman Mohammed Shorog, MSc, BCPS, BCACP, GCDF
Assistant Professor of Clinical Pharmacy
King Khalid University
Abha, Aseer Region, Saudi Arabia
Amy Skiff, PharmD, MS, BCACP, DipACLM
Family Medicine Pharmacy Clinical Specialist
FSU/Lee Health Family Medicine Residency Program
Clinical Assistant Professor
Florida State University College of Medicine
Fort Myers, Florida
Maria A. Summa, PharmD, BCPS, BCACP
Pharmacy Clinical Coordinator
UConn Health
Farmington, Connecticut
Marina Suzuki, PharmD, PhD, BCPS, BCACP
Research Manager
Washington Health Care Authority
Pharmacist
Legacy Health
Olympia, Washington
John Swegle, PharmD, BCPS, BCACP
Clinical Associate Professor
University of Iowa College of Pharmacy
Clinical Pharmacist
MercyOne North Iowa Family Medicine Residency
Mason City, Iowa
Kenyu Tan, PharmD, BCACP, BCPS, BCGP
Senior Clinical Pharmacist
IHH Healthgroup Singapore
Mount Elizabeth Orchard Hospital
Singapore, Singapore
Evan Williams, PharmD, MBA, BCPS, BCACP
Director of Accreditation Services
Associate Professor of Pharmacy Practice
Roseman University of Health Sciences College of Pharmacy
Henderson, Nevada
Elizabeth Yett, PharmD, BCACP, TTS
Assistant Professor
Department of Clinical Pharmacy and Translational Science
University of Tennessee Health Science Center College of Pharmacy
Memphis, Tennessee
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ACCP and ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speaker’s bureau, or stockholder) in any amount occurring the in the last 24 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP and required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identify and resolve conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
Faculty Disclosures:
Consultant/Member of Advisory Board: Shubha Bhat (AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Celltrion, Eli Lilly, Pfizer), David K. Choi (AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Janssen Pharmaceuticals, Pfizer), Diana Isaacs (Medtronic, Tandem), Molly G. Minze (Endocrine/Vaccine Monographs – Wolters Kluwer-Lexicomp), Elizabeth Van Dril (Novo Nordisk)
Employee: Alicia B. Forinash (Spouse – Bayer)
Royalties: Alicia B. Forinash (Wolters Kluwer)
Stock Shareholder: Alicia B. Forinash (Spouse – Bayer); Jessica Tilton (Moderna, Pfizer, Viatris)
Speaker’s Bureau: David K. Choi (AbbVie, Eli Lilly, Janssen Pharmaceuticals), Diana Isaacs (Abbott, CeQur, Dexcom, Insulet, Lilly, Mankind, Novo Nordisk, Sanofi), Melissa Lipari (Premier CE)
Nothing to Disclose: Brandi L. Bowers, Erica Crannage, Spencer H. Durham, Nicole M. Hahn, Adam B. Jackson, Zachary Klick, Hanlin Li, Jamie L. McConaha, Emily K. McCoy, Melissa C. Palmer, Emily B. Walsh
Reviewer Disclosures:
Advisory Board: Lavinia Salama (Dexcom), Joseph Saseen (Data Safety Monitoring Board for TIMI Group)
Nothing to Disclose: Teresa Bailey, Julie Bartell, Laura Challen, Megan Chynoweth, Melanie K. Claborn, Kristen Cook, Jennifer S. Dizney, Ariel D. Ferdock, Rhianna M. Fink, Benjamin Neil Gross, Jason L. Isch, Alana Juodvalkis, Karen Kier, Chelsey Llayton, Kayla Marvin, Ana Muscarella, Albert Joseph Nosser Jr, Casey Owen, Rakeshkumar Patel, Ann M. Philbrick, Lalita Prasad-Reddy, Melanie Keaton Proffitt, Kristi Quairoli, Rafael Sánchez, Kyle V. Sheffer, Eman Mohammed Shorog, Amy Skiff, Maria A. Summa, Marina Suzuki, John Swegle, Kenyu Tan, Evan Williams, Elizabeth Yett
All relevant financial relationships with ineligible companies listed have been mitigated.
All other planners, presenters, reviewers, ASHP and ACCP, and others with an opportunity to control content report no financial relationships relevant to this activity.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.
Methods and CE Requirements
Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Development
ACCP and ASHP collaborate on ambulatory care activities.
To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.